Elevated levels of activated Stat3 (p-Stat3) were shown to initiate Myostatin-mediated muscle wasting and inflammation in patients with CKD or diabetes via increase in C/EBP δ levels (Zhang et al., 2013). Here, STAT3 is linked to diabetes mellitus.